Research on Parkinson disease.
Slevin
John T
JT
Gerhardt
Greg A
GA
Smith
Charles D
CD
Gash
Don M
DM
Kryscio
Richard
R
Young
Byron
B
D000978:Antiparkinson Agents / Q000008:administration & dosage*; D002408:Catheters, Indwelling; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006801:Humans; D007260:Infusion Pumps; D009043:Motor Activity / Q000187:drug effects*; D009048:Motor Skills / Q000187:drug effects; D009414:Nerve Growth Factors / Q000008:administration & dosage*; D009460:Neurologic Examination / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D011699:Putamen / Q000187:drug effects*; D011930:Reaction Time / Q000187:drug effects
D000978:Antiparkinson Agents; C495039:GDNF protein, human; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009414:Nerve Growth Factors